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TITLE OF CASE
Idiopathic combined adrenocorticotropin and growth hormone deficiency 
mimicking chronic fatigue syndrome
SUMMARY
A 42-year-old man who had suffered from severe fatigue for 5 years was diagnosed as having chronic 
fatigue syndrome (CFS) and fibromyalgia.  Endocrinological workup using combined anterior pituitary 
function tests showed that the patient had adrenocorticotropin (ACTH) deficiency, with a normal 
pituitary MRI.  Treatment with a physiologic dose of oral hydrocortisone replacement physically 
ameliorated his general fatigue.  A secondary workup using a growth hormone-releasing peptide-2 
(GHRP-2) test revealed that he also had growth hormone (GH) deficiency, and GH replacement therapy 
was started. His muscle pain and depression were improved by the therapy. Here we present a rare case 
of combined deficiency of ACTH and GH in a middle-aged man with severe general fatigue.  This case 
report aims to raise awareness of combined deficiency of ACTH and GH as a differential diagnosis of CFS 
and its mimics. 
BACKGROUND
Adrenocorticotropin (ACTH) deficiency is well described as isolated ACTH deficiency (IAD). IAD is 
characterized by secondary adrenal insufficiency with low levels of ACTH and serum cortisol but normal 
levels of other pituitary hormones and a normal pituitary structure on radiological imaging. IAD was first 
reported by Steinberg in 1954.[1]  Over 300 cases of IAD were reported between 1969 and 1994 in Japan, 
and an increasing number of cases have been reported since then.[2] The prevalences of diagnosed cases 
have been reported to be 1.91/1 000 000 in Miyazaki Prefecture, 7.3/1 000 000 in Tokushima area and 
3.8/1 000 000 in Chuetsu district in Japan.[3 4] Adrenal deficiency may result in lassitude, fatigue, 
anorexia, weight loss, myalgia, and arthralgia.[2]  IAD can be caused by an autoimmune mechanism by 
anti-pituitary antibodies, ACTH-producing cell depletion, and lymphocytic infiltration into the anterior 
pituitary gland. However, these have not been proven in many cases. As one of the congenital factors, it 
has been revealed that TPIT mutation can cause IAD.[5]  Congenital hypopituitarism has been shown to 
be related to pituitary stalk interruption syndrome, in which several transcriptional factor genes are 
mutated.[6]  On the other hand, it is thought that an autoimmune mechanism is involved in the etiology 
of IAD because one-third to half of the cases of IAD are associated with autoimmune diseases such as 
Hashimoto's disease.[7 8]  Other etiologies include post-traumatic ACTH deficiency, Sheehan’s syndrome, 
radiation and chronic opiate use.[9]
Some patients with ACTH deficiency have shown impairment of growth hormone (GH) 
secretion, which normalized after glucocorticoid replacement therapy.[10 11]  It has been reported that 
glucocorticoids have long-term stimulatory effects on growth hormone synthesis, improve the sensitivity 
to GH-releasing hormone and control GH gene transcription in human somatotrophs.[12]  
In this report, we present a case of combined deficiency of anterior pituitary hormones (ACTH 
and GH) in a middle-aged man with severe general fatigue.
CASE PRESENTATION
A 42-year-old man with a history of severe generalized fatigue for five years was diagnosed with chronic 
fatigue syndrome (CFS) and fibromyalgia.  Prior to his diagnosis, he was able to work as a cleaner.  
However, he stopped working because of fatigue. He also complained of muscle pain, loss of appetite 
and sleep disturbances.  His fatigue worsened gradually, prompting his referral from a pain clinic to our 
general medicine department for further evaluation.  His past medical history was significant for inguinal 
hernia repair fifteen years ago.  He had no relevant family history.  He had no history of glucocorticoid 
treatment and no use of opiates. 
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He was a former smoker (18 pack years quitting at the age of 38 years) but denied a history of 
alcohol use.  His home medication included occasional use of nonsteroidal anti-inflammatory medication, 
loxoprofen.  He had a negative history of opiate use. Additionally, he was depressed with an SDS (self-
rating depression scale) score of 45 at arrival to our department and a score of 52 five years ago when he 
was diagnosed with CFS and fibromyalgia. The cut-off SDS score for a positive diagnosis is 39 and indicate 
greater depressive status.[13]
On examination, he was hemodynamically stable with a heart rate of 76 beats per minute and 
blood pressure of 121/76 mmHg. He weighed 63.9 kg and had a normal body mass index of 20.0 (kg/m2). 
Examination of the skin was unremarkable for hyperpigmentation. He was well-hydrated. There was no 
thyromegaly. Musculoskeletal examination revealed tenderness in multiple muscle groups including the 
triceps, lumbar region, hip, and hamstrings. 
INVESTIGATIONS If relevant
Laboratory data on presentation are shown in Table 1.  Of significance, the patient had extremely low 
levels of ACTH, cortisol and IGF-I. Complete blood count and liver function tests were normal. 
Table 1. Initial laboratory evaluation
Analyte Result Reference interval
Sodium (mmol/L) 139 138-145
Potassium (mmol/L) 3.9 3.6-4.8
Calcium (mg/dL) 9.0 8.8-10.1
Phosphate (mg/dL) 3.7 2.7-4.6
Magnesium (mg/dL) 1.7 2.0-2.5
Creatinine (mg/dL) 0.76 0.65-1.07
eGFR (mL/min/1.73 m2) 90.2
Hemoglobin A1c (%) 5.1 4.9-6.0
Cortisol (µg/dL) <1 4.5-21.1
ACTH (pg/mL) <1.5 7.2-63.3
FT4 (ng/dL) 0.78 0.97-1.69
TSH (µU/mL) 10.8 0.33-4.05
FSH (mIU/mL) 8.9 1.3-17.0
LH (mIU/mL) 6.2 0.5-7.8
PRL (ng/mL) 46.4 3.0-17.3
Total Testosterone (ng/mL) 5.42 1.87-9.02
GH (ng/mL) 0.04 0-2.47
IGF-I (ng/mL) 46 93-259 (age/sex adjusted)[14]
Urinary Aldosterone (µg/day) 6.5 2-10
24-hour Urinary Free Cortisol (µg/day) 1.2 26-187
Anti-Thyroglobulin antibody Positive -
Anti-Thyroid Peroxidase antibody Negative -
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Anti-Pituitary antibody Negative -
・eGFR, estimated glomerular filtration rate; ACTH, adrenocorticotrophic hormone; FT4, free thyroxine 4; 
TSH, thyrotropin; FSH, follicle-stimulating hormone; LH, luteinizing hormone; PRL, prolactin; GH, growth 
hormone, IGF-I, insulin-like growth factor I.
・Urinary free cortisol was measured when taking hydrocortisone at 5 mg/day.
An abdominal CT scan showed bilateral adrenal atrophy.  Pituitary MRI sagittal and coronal 
views were unremarkable(Figure 1).  Anterior pituitary hormonal evaluation showed no response of 
cortisol with ACTH. The ACTH level after CRH stimulation remained significantly low (up to 2.2 pg/mL) 
and cortisol secretion continued to be markedly suppressed (<1.5 µg/dL) (Figure 2). These results 
confirmed secondary adrenal insufficiency to be the underlying etiology. The evaluation also showed 
impaired secretion of GH (<9 ng/mL) in a growth hormone-releasing peptide-2 (GHRP-2) tolerance test 
(maximum GH level of 5.28 ng/mL; 30 min) (Figures 3). This result met the diagnostic criteria of GHD in 
Japan.[15] A secondary workup of the GHRP-2 test was performed six months after the first examination. 
These two GHRP-2 tests showed that GH secretion was not adequate despite hydrocortisone 
administration. Finally, we made a diagnosis of combined ACTH and GH deficiency.
DIFFERENTIAL DIAGNOSIS If relevant
A diagnosis of secondary adrenal insufficiency and adult growth hormone deficiency (AGHD) was made in 
this case.  Other endocrine diseases that cause general fatigue have been reported to be Cushing’s 
disease, hypo/hyperthyroidism, and diabetes mellitus.[16 17]  The following findings also suggested that 
the aetiology of ACTH deficiency in this case was idiopathic: negative result for anti-pituitary antibody, 
normal level of IgG4 (24.4 mg/dL) and normal pituitary MRI.  The possibility of sarcoidosis, granuloma, or 
histiocytosis was considered, but the findings indicated that such a possibility was unlikely. 
TREATMENT If relevant
Treatment was initiated with hydrocortisone at 5 mg orally in the morning with dose escalation to 10 mg 
daily over a 3-month period.  Therapy was continued for 6 months, and re-examination of the secretion 
of growth hormone showed that the level was still low (Figure 3).  Due to the continuous low level of GH, 
we started treatment with somatropin at 0.6 mg per week one year after being diagnosed with IAD and 
AGHD.
OUTCOME AND FOLLOW-UP
Clinically, symptoms of general fatigue and muscle pain improved and his body weight increased from 
63.3 kg to 74.7 kg during a period of 9 months after diagnosis of IAD.  Furthermore, he had a more 
muscular physique, and his mood and endurance were improved after GH replacement therapy.  His 
serum IGF-I level increased to 107 ng/mL and his body weight increased to 78.4 kg during a one-year 
period of treatment with somatropin (Figure 4).  Furthermore, although his psychological status was 
depressive (self-rating depression scale: SDS of 45 points) before the replacement therapy, it improved to 
an SDS score of 38 points within 18 months after starting dual treatment. 
DISCUSSION Include a very brief review of similar published cases
Most patients with primary adrenal insufficiency experience a nonspecific symptom of fatigue.[2]  
Fatigue combined with gastrointestinal or musculoskeletal complaints often leads to an incorrect 
diagnosis.  One study showed that 20 percent of patients with primary adrenal insufficiency had 
symptoms for more than five years before diagnosis.[18]
Very low secretion of pituitary ACTH is well described as IAD.  IAD is a rare clinical entity that is 
characterized by a low level of serum cortisol and decreased production of ACTH with normal secretion 
of other anterior pituitary hormones and normal pituitary imaging.[19 20]  The etiologies of IAD remain 
unclear, but autoantibodies to pituitary cells were detected in some cases of IAD,[21 22] and the disease 
is presumed to be induced partially by an autoimmune mechanism such as lymphocytic hypophysitis.[23]  
A relationship between chronic thyroiditis (Hashimoto’s thyroiditis) and IAD has also been reported.[7 
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24]  Our case had a positive anti-TPO antibody, high level of TSH, and low level of free T4 before the 
hydrocortisone replacement therapy, indicating a possible relationship between IAD and the 
autoimmune process.  Additionally, TSH can be mildly elevated (10.8 µU/mL at the initial evaluation) 
given that there is no physiological inhibitory effect of cortisol on TSH.[10]  Our patient’s TSH improved to 
4.01 µU/mL without taking levothyroxine once his cortisol was replaced.  Furthermore, although chronic 
opiate use is also an important etiology of IAD,[9] he had a negative history of opiate use.
Some patients with ACTH deficiency have shown impairment of GH secretion, which was 
normalized after glucocorticoid replacement therapy.[10 11]  It has been reported that glucocorticoids 
have long-term stimulatory effects on growth hormone synthesis, improve the sensitivity to GRH and 
control GH gene transcription in human somatotrophs.[12]  This phenomenon is described as Giustina’s 
effect.[25]  In our case, despite taking hydrocortisone for six months, the secretion of GH did not recover.  
One possible reason for this is that the long-term absence of ACTH and cortisol stimulus caused a 
dysfunction in secretion of GH from the pituitary.
In summary, we presented the clinical course of a middle-aged man who suffered from fatigue 
for five years and was finally diagnosed with combined ACTH and GH deficiency with a structurally 
normal pituitary gland on MRI.  This combined pathophysiological status probably represented his 
physical and mental conditions.  His physical general fatigue was improved with glucocorticoid and GH 
replacement therapy.  Although ACTH deficiency is more common in older men, this case indicates the 
importance for physicians to consider the possibility of this rare but important disease in patients who 
have general fatigue.
LEARNING POINTS/TAKE HOME MESSAGES 3-5 bullet points
► Combined deficiency of ACTH and GH may mimic chronic fatigue syndrome. 
► All doctors should check for evidence of ACTH and/or GH deficiency in patients who complain of 
fatigue to improve the timely diagnosis for this potentially serious but curable condition.
►GH replacement therapy may improve muscle pain, mood and endurance in a patient with deficiency 
of GH.
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FIGURE/VIDEO CAPTIONS
Figure 1. (A) Abdominal CT scan: Bilateral atrophic adrenal glands were shown by CT. MRI in sagittal (B) 
and coronal (C) views: No morphological changes in the pituitary gland were detected. 
Figure 2. Anterior pituitary hormonal evaluation: Endocrine tests were performed using stimulations with 
corticotropin-releasing hormone (CRH), thyrotropin-releasing hormone (TRH), gonadotropin-releasing 
hormone (GnRH) and growth hormone-releasing hormone (GRH).
Figure 3. Growth hormone responses to growth hormone-releasing peptide (GHRP)-2 stimulations. The 
dotted line represents the reference level of growth hormone secretion in growth hormone deficiency (9 
ng/mL), which is a diagnostic criterion of severe GHD in Japan.
Figure 4. Clinical course and body images during replacement therapy.
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PATIENT’S PERSPECTIVE
I appreciate having been diagnosed and successfully treated with hydrocortisone and somatropin, which 
improved my general fatigue.  I am now feeling well enough to be able to work and am trying to find a 
job.
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(A) Abdominal CT scan: Bilateral atrophic adrenal glands were shown by CT. MRI in sagittal (B) and coronal 
(C) views: No morphological changes in the pituitary gland were detected. 
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Anterior pituitary hormonal evaluation: Endocrine tests were performed using stimulations with 
corticotropin-releasing hormone (CRH), thyrotropin-releasing hormone (TRH), gonadotropin-releasing 
hormone (GnRH) and growth hormone-releasing hormone (GRH). 
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Growth hormone responses to growth hormone-releasing peptide (GHRP)-2 stimulations. The dotted line 
represents the reference level of growth hormone secretion in growth hormone deficiency (9 ng/mL), which 
is a diagnostic criterion of severe GHD in Japan. 
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Clinical course and body images during replacement therapy. 
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